Product Images Metformin Hydrochloride
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 10 images provide visual information about the product associated with Metformin Hydrochloride NDC 50090-0771 by A-s Medication Solutions, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Table-1 - Metformin 2
The text describes a table showing the pharmacokinetic parameters of Metformin following single or multiple oral doses of Metformin Hydrochloride Tablets among different subject groups, including healthy adults, adults with type 2 diabetes, elderly, and renal-impaired adults. The table presents various measurements such as renal clearance rate, number of subjects, and doses given over a period of time.*
Table-2 - Metformin 3
The table compares the effects of Metformin Hydrochloride Tablets, USP versus a placebo on fasting plasma glucose, HbAq, and body weight in a 20-week study. The results show a significant decrease in fasting plasma glucose and HbAq for the group that received Metformin compared to the placebo, but there was no significant difference in body weight between the two groups.*
Table-3 - Metformin 4
Table-4 - Metformin 5
This text presents a table (Table 4) that summarizes the mean percent change from baseline of major serum lipid variables in 29-week studies. The table compares the effects of Metformin, Placebo, Metformin/Glyburide combined, and Glyburide on Total Cholesterol and LDL-Cholesterol levels. It provides the number of participants for each treatment and the baseline values of the variables measured. The table also displays the percentage of change for each variable at the final visit for each treatment option.*
Table-5 - Metformin 6
Table-6 - Metformin 7
This appears to be a comparison of the effects of metformin hydrochloride tablets versus placebo in some pediatric population. The table shows the mean changes from baseline in FPG (fasting plasma glucose) and body weight at the final visit. The results suggest that metformin hydrochloride tablets resulted in a significant decrease in FPG and a slight increase in body weight. However, due to incomplete information and unclear context, it is difficult to interpret the data fully.*
Table-7 - Metformin 8
Label Image - lbl500900771
Label Image - lbl500900777
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
